<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Presently, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is staged preoperatively by radiographic tests, and postoperatively by pathological evaluation of available surgical specimens </plain></SENT>
<SENT sid="1" pm="."><plain>However, present staging methods do not accurately identify occult <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>This has a direct effect on clinical management </plain></SENT>
<SENT sid="3" pm="."><plain>Early identification of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> isolated to the liver may enable surgical resection, whereas more disseminated disease may be best treated with palliative chemotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Sera from 103 patients with colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> treated at the same tertiary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> center were analyzed by proton nuclear magnetic resonance (1H NMR) spectroscopy and gas chromatography-mass spectroscopy (GC-MS) </plain></SENT>
<SENT sid="5" pm="."><plain>Metabolic profiling was done using both supervised pattern recognition and orthogonal partial least squares-discriminant analysis (O-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PLS</z:e>-<z:mp ids='MP_0000273'>DA</z:mp>) of the most significant metabolites, which enables comparison of the whole sample spectrum between groups </plain></SENT>
<SENT sid="6" pm="."><plain>The metabolomic profiles generated from each platform were compared between the following groups: locoregional <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (N = 42); liver-only <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> (N = 45); and extrahepatic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> (N = 25) </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The serum metabolomic profile associated with locoregional <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> was distinct from that associated with liver-only <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>, based on 1H NMR spectroscopy (P = 5.10 × 10-7) and GC-MS (P = 1.79 × 10-7) </plain></SENT>
<SENT sid="8" pm="."><plain>Similarly, the serum metabolomic profile differed significantly between patients with liver-only <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> and with extrahepatic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The change in metabolomic profile was most markedly demonstrated on GC-MS (P = 4.75 × 10-5) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, the serum metabolomic profile changes markedly with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, and site of disease also appears to affect the pattern of circulating metabolites </plain></SENT>
<SENT sid="11" pm="."><plain>This novel observation may have clinical utility in enhancing staging accuracy and selecting patients for surgical or medical management </plain></SENT>
<SENT sid="12" pm="."><plain>Additional studies are required to determine the sensitivity of this approach to detect subtle or occult <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> </plain></SENT>
</text></document>